CN Patent
CN102432593A — 光学活性的3-(邻苯二甲酰亚氨基)哌啶及其制备方法
Assigned to Boehringer Ingelheim International GmbH · Expires 2012-05-02 · 14y expired
What this patent protects
本发明涉及具有光学活性的3-(邻苯二甲酰亚氨基)哌啶、其酒石酸盐及其制备方法。
USPTO Abstract
本发明涉及具有光学活性的3-(邻苯二甲酰亚氨基)哌啶、其酒石酸盐及其制备方法。
Drugs covered by this patent
- Jardiance (empagliflozin) · Boehringer Ingelheim
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.